tiprankstipranks
The Fly

Biden demands Novo Nordisk, Lilly lower GLP-1 drug prices in USAToday editorial

Biden demands Novo Nordisk, Lilly lower GLP-1 drug prices in USAToday editorial

U.S. President Joe Biden is demanding price cuts on blockbuster drugs for diabetes and weight loss from Novo Nordisk (NVO) and Eli Lilly (LLY), saying in an editorial with Vermont Senator Bernie Sanders published in USAToday that the companies are charging “unconscionably high prices” that are above those paid in other countries. If “pharmaceutical companies refuse to substantially lower prescription drug prices in our country and end their greed, we will do everything within our power to end it for them,” Biden said.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com